MARC details
| 000 -LEADER |
| fixed length control field |
01242 a2200493 4500 |
| 000 - LEADER |
| fixed length control field |
BKB |
| 001 - CONTROL NUMBER |
| control field |
145259 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20200902170919.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
|
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
| LC control number |
|
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9780971176799 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
| Classification number |
615.19 |
| Item number |
B64P |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
| Personal name |
|
| Dates associated with a name |
|
| 110 ## - MAIN ENTRY--CORPORATE NAME |
| Corporate name or jurisdiction name as entry element |
|
| 245 1# - TITLE STATEMENT |
| Title |
Pharmaceutical profiling in drug discovery for lead selection |
| Statement of responsibility, etc |
edited by Ronald T. Borchardt...[et. al.] |
| 250 ## - EDITION STATEMENT |
| Edition statement |
|
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
| Place of publication, distribution, etc |
Arlington |
| Name of publisher, distributor, etc |
American Association of Pharmaceutical |
| Date of publication, distribution, etc |
2004 |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
482p. |
| 490 ## - SERIES STATEMENT |
| Series statement |
Biotechnology: pharmaceutical aspects/ edited by Ronald T. Borchardt and C. Russell Middaugh |
| 500 ## - GENERAL NOTE |
| General note |
|
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME |
| Personal name |
|
| 610 ## - SUBJECT ADDED ENTRY--CORPORATE NAME |
| Corporate name or jurisdiction name as entry element |
|
| 611 ## - SUBJECT ADDED ENTRY--MEETING NAME |
| Meeting name or jurisdiction name as entry element |
|
| 630 ## - SUBJECT ADDED ENTRY--UNIFORM TITLE |
| Uniform title |
Pharmacy |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
|
| 651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
| Geographic name |
|
| 654 ## - SUBJECT ADDED ENTRY--FACETED TOPICAL TERM |
| Focus term |
|
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
| Topical term or geographic name as entry element |
Pharmaceutical chemistry; Drug development |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Borchardt, Ronald T., ed. |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Kerns, Edward, ed. |
| Numeration |
|
| Titles and other words associated with a name |
|
| 700 ## - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Lipinski, Christopher, ed. |
| Numeration |
|
| Titles and other words associated with a name |
|
| 700 ## - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Thakker, Dhrien, ed. |
| Numeration |
|
| Titles and other words associated with a name |
|
| 700 ## - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Wang, Binghe, ed. |
| Numeration |
|
| Titles and other words associated with a name |
|
| 710 ## - ADDED ENTRY--CORPORATE NAME |
| Corporate name or jurisdiction name as entry element |
|
| Subordinate unit |
|
| Location of meeting |
|
| 711 ## - ADDED ENTRY--MEETING NAME |
| Meeting name or jurisdiction name as entry element |
|
| 720 ## - ADDED ENTRY--UNCONTROLLED NAME |
| Name |
|
| 730 ## - ADDED ENTRY--UNIFORM TITLE |
| Uniform title |
|
| 740 ## - ADDED ENTRY--UNCONTROLLED RELATED/ANALYTICAL TITLE |
| Uncontrolled related/analytical title |
|
| 752 ## - ADDED ENTRY--HIERARCHICAL PLACE NAME |
| Country or larger entity |
|
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
| Host name |
|
| Path |
|
| Electronic name |
|
| 904 ## - LOCAL DATA ELEMENT D, LDD (RLIN) |
| a |
|
| 964 ## - |
| -- |
|
| -- |
|
| -- |
|
| -- |
|
| -- |
|
| -- |
|
| -- |
|
| 965 ## - |
| -- |
|